You can also catch Felicia Irvin this Friday during the summit as she speaks during one of the conference sessions!
November 18, 12:00 to 12:50 PM “Connecting people, data, and technology to make a substantial, lasting, and measurable impact on patient and site burden” Abstract: The pharma industry’s strong focus on alleviating patient and site burden in clinical trials stems from the effect burden has on study success. But it’s a hard goal to achieve – for a single study, let alone at scale across an entire portfolio of trials. Stakeholders from different facets of the clinical trial industry – patient, site, sponsor, and data/tech/service providers – will come together to discuss what patient and site burden means to them; how it is addressed in clinical trial planning and execution today; what meaningful improvement looks like; and how we can connect people, data, and technology to make significant, sustainable improvements for all.
Later in the month from November 28th – December 1st, Michael Casey and Felicia Irvin will head to San Diego, California to join Van Johnson, VP of Commercial Strategy at Benchmark Research for World Vaccine & Immunotherapy Congress West Coast! We’ll be joining our VaxCorps colleagues as we learn more about the ground-breaking work being done for vaccine research and immunotherapies, and hopefully connecting with new industry professionals and developing exciting partnerships.